Adicet Bio Stock Today
| ACET Stock | USD 0.91 0.01 1.09% |
Performance0 of 100
| Odds Of DistressOver 60
|
Adicet Bio is selling for under 0.91 as of the 18th of January 2025; that is 1.09 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.88. Adicet Bio has more than 60 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 18th of January 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 26th of January 2018 | Category Healthcare | Classification Health Care |
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. The company has 82.4 M outstanding shares of which 3.37 M shares are presently shorted by private and institutional investors with about 7.04 trading days to cover. More on Adicet Bio
Moving against Adicet Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Adicet Stock Highlights
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Providers & Services, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAdicet Bio can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Adicet Bio's financial leverage. It provides some insight into what part of Adicet Bio's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adicet Bio (ACET) is traded on NASDAQ Exchange in USA. It is located in 131 Dartmouth Street, Boston, MA, United States, 02116 and employs 143 people. Adicet Bio is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 75.78 M. Adicet Bio conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 82.4 M outstanding shares of which 3.37 M shares are presently shorted by private and institutional investors with about 7.04 trading days to cover.
Adicet Bio currently holds about 260.64 M in cash with (93.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Adicet Bio Probability Of Bankruptcy
Ownership AllocationAdicet Bio holds a total of 82.4 Million outstanding shares. The majority of Adicet Bio outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Adicet Bio to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Adicet Bio. Please pay attention to any change in the institutional holdings of Adicet Bio as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Adicet Ownership Details
Adicet Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bridgeway Capital Management, Llc | 2024-09-30 | 851.6 K | |
| Geode Capital Management, Llc | 2024-09-30 | 768.6 K | |
| Blackrock Inc | 2024-09-30 | 752 K | |
| Two Sigma Advisers, Llc | 2024-09-30 | 706.6 K | |
| Two Sigma Investments Llc | 2024-09-30 | 703.4 K | |
| Alyeska Investment Group, L.p. | 2024-09-30 | 655.7 K | |
| Stonepine Capital Management Llc | 2024-09-30 | 609.4 K | |
| Rbf Llc | 2024-09-30 | 601.1 K | |
| Dafna Capital Management Llc | 2024-09-30 | 600 K | |
| Orbimed Advisors, Llc | 2024-09-30 | 11.4 M | |
| Tang Capital Management Llc | 2024-09-30 | 8.2 M |
Adicet Bio Historical Income Statement
Adicet Stock Against Markets
Adicet Bio Corporate Management
| Francesco MD | Chief VP | Profile | |
| BA CPA | Pres CEO | Profile | |
| Blake Aftab | Senior Officer | Profile | |
| Donald Healey | Chief Officer | Profile | |
| Amy Locke | Head Resources | Profile | |
| Brian Harvey | Chief Officer | Profile | |
| Aya Jakobovits | Founder Director | Profile |
Already Invested in Adicet Bio?
The danger of trading Adicet Bio is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Adicet Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Adicet Bio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Adicet Bio is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Adicet Stock Analysis
When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.